Search Results - "Bartik, Mary M"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    l-Canavanine modulates cellular growth, chemosensitivity and P-glycoprotein substrate accumulation in cultured human tumor cell lines by Worthen, David R, Chien, Lynn, Tsuboi, Clifford P, Mu, Xi Y, Bartik, Mary M, Crooks, Peter A

    Published in Cancer letters (23-10-1998)
    “…l-Canavanine (L-CAV) is a naturally occurring l-arginine analog that induces the formation of non-functional proteins in a variety of organisms. Previous…”
    Get full text
    Journal Article
  2. 2

    Activation of human peripheral blood T cells does not lead to increased P-glycoprotein expression by MU, X. Y, GOSLAND, M. P, BARTIK, M. M, SCHIMMELPFENNIG, J, KAY, N. E

    Published in Journal of clinical immunology (01-07-1999)
    “…The expression of P-glycoprotein (Pgp) on normal human lymphocytes, and its drug exclusion capacity, implies that Pgp might be involved in cytokine secretion…”
    Get full text
    Journal Article
  3. 3

    Interleukin 2 requirement for the in vitro generation of antitumor cytotoxicity by thymocytes from melphalan-cured MOPC-315 tumor bearers by Mokyr, M B, Bartik, M M, Ahn, M C

    Published in Cancer research (Chicago, Ill.) (15-02-1989)
    “…We have previously shown that enhanced antitumor cytotoxicity is generated when thymocytes from melphalan (L-phenylalanine mustard; L-PAM)-treated MOPC-315…”
    Get full text
    Journal Article
  4. 4

    Melphalan-induced enhancement of antitumor immune reactivity in thymocytes of adult BALB/c mice bearing a large MOPC-315 tumor by BARTIK, M. M, TAKESUE, B. Y, MOKYR, M. B

    Published in Cancer research (Chicago, Ill.) (15-09-1987)
    “…At no stage of tumor growth are thymocytes from MOPC-315 tumor bearers capable of bringing about the generation of enhanced antitumor cytotoxicity when added…”
    Get full text
    Journal Article
  5. 5

    Modulation of T cell proliferation by stimulation of the beta-adrenergic receptor: lack of correlation between inhibition of T cell proliferation and cAMP accumulation by Bartik, M M, Brooks, W H, Roszman, T L

    Published in Cellular immunology (01-05-1993)
    “…The presence of beta-adrenergic receptors on T cells suggests the potential for modulating T cell function upon binding of an appropriate agonist. Utilizing…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells by Bartik, M M, Bauman, G P, Brooks, W H, Roszman, T L

    Published in Cellular immunology (01-10-1994)
    “…Stimulation of highly purified human T cells with immobilized anti-CD3 monoclonal antibody (mAb) in the presence of cAMP-inducing agents results in inhibition…”
    Get more information
    Journal Article
  8. 8

    cAMP accumulation in T-cells inhibits anti-CD3 monoclonal antibody-induced actin polymerization by Selliah, Nithianandan, Bartik, Mary M., Carlson, Sonia L., Brooks, William H., Roszman, Thomas L.

    Published in Journal of neuroimmunology (1995)
    “…The results presented in this report offer a novel explanation for how stimulation of the beta-adrenergic receptor (βAR) inhibits the ability of T cells to…”
    Get full text
    Journal Article
  9. 9

    Enhanced expansion of the thymic CD8+ cell subset as a potential mechanism for the generation of enhanced antitumor cytotoxicity by thymocytes from low-dose melphalan-treated MOPC-315 tumor bearers by Bartik, M M, Baumgartel-Scofield, B A, Mokyr, M B

    Published in Cancer Immunology Immunotherapy (01-03-1991)
    “…We have previously shown that thymocytes from low-dose melphalan (L-phenylalanine mustard)-treated MOPC-315-tumor-bearing mice (melphalan TuB) are able to…”
    Get full text
    Journal Article
  10. 10

    Presence of an enlarged pool of MOPC-315-specific cytotoxic T lymphocyte precursors in the thymuses of mice that eradicated a large MOPC-315 tumor as a consequence of low-dose melphalan therapy by Bartik, M M, Ahn, M C, Baumgartel, B A, Hendricks, R L, Mokyr, M B

    Published in Cancer Immunology Immunotherapy (01-05-1990)
    “…We have previously shown that, as a consequence of low-dose melphalan (L-phenylalanine mustard) treatment, thymocytes from mice bearing a large, day-10…”
    Get full text
    Journal Article
  11. 11

    Melphalan-induced appearance of potent antitumor immune reactivity in tumor bearer lymphocytes co-expressing the Lyt 2 and the L3T4 antigens by Takesue, B Y, Bartik, M M, Mokyr, M B

    “…We have previously shown that Sephadex G-10-adherent spleen cells from mice bearing a large MOPC-315 tumor can suppress the in vitro generation of a primary…”
    Get more information
    Journal Article